title: Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
abstract: Abstract Objective. To evaluate the long-term outcome and ovarian function in premenarchal and adolescent patients with malignant ovarian germ cell tumors after fertility-preserving surgery and adjuvant chemotherapy. Design. Retrospective review of medical records. Setting. Ajou University Hospital, a tertiary care hospital in South Korea. Population. Forty-five patients with malignant ovarian germ cell tumors. Methods. A retrospective analysis of patients with malignant ovarian germ cell tumors was conducted and a statistical analysis was performed. Main outcome measures. There were 9 premenarchal and 16 adolescent patients; the median ages at diagnosis were 7 and 18 years, respectively. All patients were treated with fertility-preserving surgery. Seventeen of the patients received adjuvant chemotherapy with bleomycin, etoposide, and cisplatin (68.0%). There were no disease recurrences or deaths. Of the nine premenarchal patients, eight (88.9%) subsequently had normal menarche. Among the 16 adolescent patients, 15 (93.8%) resumed normal menstruation and 1 had premature ovarian failure. Conclusion. Premenarchal and adolescent patients with malignant ovarian germ cell tumors have excellent survival with fertility-preserving surgery and adjuvant chemotherapy. The majority of these patients can have normal menarche and menstruation.
authors.affiliation: Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, South Korea.
authors.forename: Seung-Chul
authors.initials: SC
authors.lastname: Yoo
authors.forename: Woo Young
authors.initials: WY
authors.lastname: Kim
authors.forename: Jong-Hyuck
authors.initials: JH
authors.lastname: Yoon
authors.forename: Suk-Joon
authors.initials: SJ
authors.lastname: Chang
authors.forename: Ki-Hong
authors.initials: KH
authors.lastname: Chang
authors.forename: Hee-Sug
authors.initials: HS
authors.lastname: Ryu
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D017024:Chemotherapy, Adjuvant; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008572:Menarche; D008598:Menstruation; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology* / Q000601:surgery; D012189:Retrospective Studies; D013724:Teratoma / Q000188:drug therapy / Q000601:surgery
chemical_list: D014408:Biomarkers, Tumor